Update on the molecular biology of mantle cell lymphoma
β Scribed by Francesco Bertoni; Andrea Rinaldi; Emanuele Zucca; Franco Cavalli
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 154 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0278-0232
- DOI
- 10.1002/hon.767
No coin nor oath required. For personal study only.
β¦ Synopsis
Mantle cell lymphoma (MCL) accounts for 5-10% of non-Hodgkin's lymphomas and it bears the worst prognosis among B cell lymphomas. Even more than in the other lymphomas, new insights in MCL biology are needed. In this review we will discuss the most recent published data. Immunoglobulin sequencing data suggest that the MCL cell of origin is a mature B cell which might have undergone an extra-follicular T-cell independent antigen maturation. The main aberrations that affect cell cycle and DNA repair pathways in MCL are summarized, also discussing the need of the t(11;14)(q13;q32) to make diagnosis of MCL. After the gene expression studies of the last years, now the research focus has moved towards the new opportunities provided by arrayCGH technique for gene discovery and for identification of therapeutic targets. Examples of genes identified because deleted or amplified at DNA level and that might be relevant for MCL pathogenesis are presented.
π SIMILAR VOLUMES
## Abstract Malignant mesothelioma (MM) is a highly aggressive tumor with a very poor prognosis. The disease is largely unresponsive to conventional chemotherapy or radiotherapy, and most patients die within 10β17 months of the first symptoms. Novel, more effective therapeutic strategies are needed
## Abstract Advancedβstage follicular lymphoma (FL) and mantle cell lymphoma (MCL) cannot be cured using conventional chemotherapy. Fludarabine, the most widely used purine analog, exhibits a particularly high level of activity against small lymphocytic lymphoma and chronic lymphocytic leukemia (CL
## Background: Cytologic distinction between follicle center lymphoma (fcl) and mantle cell lymphoma (mcl) is difficult with cytomorphology alone and requires immunophenotyping. the current study describes the distinction between follicle center and mantle cell lymphoma made with fine-needle aspira